関連する実験動画
Updated: Nov 16, 2025

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
13.4K
動脈硬化における幹細胞の増殖は,クローン細胞形成を加速する
Alexander Heyde1, David Rohde2, Cameron S McAlpine2
1Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Cell
|February 26, 2021
まとめ
血液形成幹細胞の増殖はクローン細胞形成を加速し,心血管疾患のリスクを高めます. この研究は,動脈硬化症患者の幹細胞分裂率が上昇していることを明らかにし,この関連性の重要な部分を説明しています.
科学分野:
- 血液学
- 心血管科学
- 遺伝学
背景:
- 変異した造血幹細胞の複製であるクローン造血は,心血管疾患 (CVD) と関連しています.
- クローナル血液形成とCVDを結びつけるメカニズムは不明である.
研究 の 目的:
- 血管新生幹細胞 (HSC) の増殖がCVDとクローン細胞形成の関連性を調査する.
- HSCの分裂率の増加が動脈硬化症におけるクローン膨張に寄与するかどうかを判断する.
主な方法:
- 動脈硬化症のマウスとヒトにおけるHSC分裂率の測定
- クロンの進化に及ぼす影響を評価するための数学的モデルを開発した.
- Tet2欠乏性HSC移植による動脈硬化と睡眠の断片化のマウスモデルを用いて検証された結果
主要な成果:
- 動脈硬化症の患者およびマウスの場合,HSC分裂率は上昇しています.
- 数学的モデリングは 増殖が体進化とクローン拡大を 加速することを示しています
- 70歳までにクローナル血液形成のリスクが3. 5倍に増加することを予測しています.
- 血液形成活動が増加した状態で観測された Tet2- / - HSCの加速膨張.
結論:
- HSCの増殖は,動脈硬化とクローン血液形成を結びつける重要なメカニズムです.
- 幹細胞分裂率の上昇は,CVDの文脈でクローナル血液形成の発生リスクに大きく寄与する.
関連する概念動画
Multipotency of Hematopoietic Stem Cells
3.5K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Atherosclerosis I: Introduction
355
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
355
Hematopoiesis
7.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.7K
Production of Formed Elements
3.0K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.0K
Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K

